{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T16:30:57Z","timestamp":1778517057046,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,8]]},"DOI":"10.7759\/cureus.31233","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T12:35:26Z","timestamp":1667910926000},"source":"Crossref","is-referenced-by-count":5,"title":["Utility of Antibodies in the Diagnoses of Thyroid Diseases: A Review Article"],"prefix":"10.7759","author":[{"given":"Amit K","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Autoimmune thyroid disease: mechanism, genetics and current knowledge","volume":"18","author":"Dong YH","year":"2014","unstructured":"Dong YH, Fu DG. Autoimmune thyroid disease: mechanism, genetics and current knowledge. Eur Rev Med Pharmacol Sci. 2014, 18:3611-8.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000343834","article-title":"The immunopathogenesis of chronic autoimmune thyroiditis one century after hashimoto","volume":"1","author":"Weetman AP","year":"2013","unstructured":"Weetman AP. The immunopathogenesis of chronic autoimmune thyroiditis one century after hashimoto. Eur Thyroid J. 2013, 1:243-50. 10.1159\/000343834","journal-title":"Eur Thyroid J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032142","article-title":"Toward precise forecasting of autoimmune endocrinopathy","volume":"89","author":"Pearce SH","year":"2004","unstructured":"Pearce SH, Leech NJ. Toward precise forecasting of autoimmune endocrinopathy. J Clin Endocrinol Metab. 2004, 89:544-7. 10.1210\/jc.2003-032142","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(85)80446-4","article-title":"Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases","volume":"190","author":"Czarnocka B","year":"1985","unstructured":"Czarnocka B, Ruf J, Ferrand M, Carayon P, Lissitzky S. Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases. FEBS Lett. 1985, 190:147-52. 10.1016\/0014-5793(85)80446-4","journal-title":"FEBS Lett"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-71-3-661","article-title":"Antithyroid peroxidase autoantibodies in thyroid diseases","volume":"71","author":"Mariotti S","year":"1990","unstructured":"Mariotti S, Caturegli P, Piccolo P, Barbesino G, Pinchera A. Antithyroid peroxidase autoantibodies in thyroid diseases. J Clin Endocrinol Metab. 1990, 71:661-9. 10.1210\/jcem-71-3-661","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-18-7-699","article-title":"The presence of an abnormal thyroid-stimulating hormone in the serum of some thyrotoxic patients","volume":"18","author":"Adams DD","year":"1958","unstructured":"Adams DD. The presence of an abnormal thyroid-stimulating hormone in the serum of some thyrotoxic patients. J Clin Endocrinol Metab. 1958, 18:699-712. 10.1210\/jcem-18-7-699","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.03.012","article-title":"TSH receptor autoantibodies","volume":"9","author":"Michalek K","year":"2009","unstructured":"Michalek K, Morshed SA, Latif R, Davies TF. TSH receptor autoantibodies. Autoimmun Rev. 2009, 9:113-6. 10.1016\/j.autrev.2009.03.012","journal-title":"Autoimmun Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(85)90146-1","article-title":"A high prevalence of thyroglobulin autoantibodies in adults with and without thyroid disease as measured with a sensitive solid-phase immunosorbent radioassay","volume":"37","author":"Ericsson UB","year":"1985","unstructured":"Ericsson UB, Christensen SB, Thorell JI. A high prevalence of thyroglobulin autoantibodies in adults with and without thyroid disease as measured with a sensitive solid-phase immunosorbent radioassay. Clin Immunol Immunopathol. 1985, 37:154-62. 10.1016\/0090-1229(85)90146-1","journal-title":"Clin Immunol Immunopathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021460","article-title":"PDS is a new susceptibility gene to autoimmune thyroid diseases: association and linkage study","volume":"88","author":"Hadj Kacem H","year":"2003","unstructured":"Hadj Kacem H, Rebai A, Kaffel N, Masmoudi S, Abid M, Ayadi H. PDS is a new susceptibility gene to autoimmune thyroid diseases: association and linkage study. J Clin Endocrinol Metab. 2003, 88:2274-80. 10.1210\/jc.2002-021460","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1732","article-title":"Pendrin is a novel autoantigen recognized by patients with autoimmune thyroid diseases","volume":"94","author":"Yoshida A","year":"2009","unstructured":"Yoshida A, Hisatome I, Taniguchi S, et al.. Pendrin is a novel autoantigen recognized by patients with autoimmune thyroid diseases. J Clin Endocrinol Metab. 2009, 94:442-8. 10.1210\/jc.2008-1732","journal-title":"J Clin Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2002.17.3.293","article-title":"Clinical applications of TSH receptor antibodies in thyroid diseases","volume":"17","author":"Cho BY","year":"2002","unstructured":"Cho BY. Clinical applications of TSH receptor antibodies in thyroid diseases. J Korean Med Sci. 2002, 17:293-301. 10.3346\/jkms.2002.17.3.293","journal-title":"J Korean Med Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291x(89)92727-7","article-title":"Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor","volume":"165","author":"Nagayama Y","year":"1989","unstructured":"Nagayama Y, Kaufman KD, Seto P, Rapoport B. Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. Biochem Biophys Res Commun. 1989, 165:1184-90. 10.1016\/0006-291x(89)92727-7","journal-title":"Biochem Biophys Res Commun"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/0888-7543(90)90276-z","article-title":"Assignment of the human thyroid stimulating hormone receptor (TSHR) gene to chromosome 14q31","volume":"8","author":"Rousseau-Merck MF","year":"1990","unstructured":"Rousseau-Merck MF, Misrahi M, Loosfelt H, Atger M, Milgrom E, Berger R. Assignment of the human thyroid stimulating hormone receptor (TSHR) gene to chromosome 14q31. Genomics. 1990, 8:233-6. 10.1016\/0888-7543(90)90276-z","journal-title":"Genomics"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.19.6.0352","article-title":"The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies","volume":"19","author":"Rapoport B","year":"1998","unstructured":"Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM. The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev. 1998, 19:673-716. 10.1210\/edrv.19.6.0352","journal-title":"Endocr Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3109\/08916938909019959","article-title":"Assays of TSH-receptor antibodies in 576 patients with various thyroid disorders: their incidence, significance and clinical usefulness","volume":"3","author":"Macchia E","year":"1989","unstructured":"Macchia E, Concetti R, Borgoni F, Cetani F, Fenzi GF, Pinchera A. Assays of TSH-receptor antibodies in 576 patients with various thyroid disorders: their incidence, significance and clinical usefulness. Autoimmunity. 1989, 3:103-12. 10.3109\/08916938909019959","journal-title":"Autoimmunity"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-4309","article-title":"Clinical review: clinical utility of TSH receptor antibodies","volume":"98","author":"Barbesino G","year":"2013","unstructured":"Barbesino G, Tomer Y. Clinical review: clinical utility of TSH receptor antibodies. J Clin Endocrinol Metab. 2013, 98:2247-55. 10.1210\/jc.2012-4309","journal-title":"J Clin Endocrinol Metab"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2010.0417","article-title":"Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists","volume":"21","author":"Bahn Chair RS","year":"2011","unstructured":"Bahn Chair RS, Burch HB, Cooper DS, et al.. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011, 21:593-646. 10.1089\/thy.2010.0417","journal-title":"Thyroid"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0180","article-title":"Approach to the patient with amiodarone-induced thyrotoxicosis","volume":"95","author":"Bogazzi F","year":"2010","unstructured":"Bogazzi F, Bartalena L, Martino E. Approach to the patient with amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab. 2010, 95:2529-35. 10.1210\/jc.2010-0180","journal-title":"J Clin Endocrinol Metab"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(96)00259-8","article-title":"Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha","volume":"101","author":"Roti E","year":"1996","unstructured":"Roti E, Minelli R, Giuberti T, et al.. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha. Am J Med. 1996, 101:482-7. 10.1016\/s0002-9343(96)00259-8","journal-title":"Am J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2000.10.809","article-title":"Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease","volume":"10","author":"Noh JY","year":"2000","unstructured":"Noh JY, Hamada N, Inoue Y, Abe Y, Ito K, Ito K. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease. Thyroid. 2000, 10:809-13. 10.1089\/thy.2000.10.809","journal-title":"Thyroid"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03696.x","article-title":"Natural history of subclinical hyperthyroidism in elderly patients with TSH between 0.1 and 0.4 mIU\/l: a prospective study","volume":"72","author":"Rosario PW","year":"2010","unstructured":"Rosario PW. Natural history of subclinical hyperthyroidism in elderly patients with TSH between 0.1 and 0.4 mIU\/l: a prospective study. Clin Endocrinol (Oxf). 2010, 72:685-8. 10.1111\/j.1365-2265.2009.03696.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00220","article-title":"Clinical guidelines and PTH measurement: does assay generation matter?","volume":"40","author":"Smit MA","year":"2019","unstructured":"Smit MA, van Kinschot CM, van der Linden J, van Noord C, Kos S. Clinical guidelines and PTH measurement: does assay generation matter?. Endocr Rev. 2019, 40:1468-80. 10.1210\/er.2018-00220","journal-title":"Endocr Rev"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1997.7.369","article-title":"Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment","volume":"7","author":"Vitti P","year":"1997","unstructured":"Vitti P, Rago T, Chiovato L, et al.. Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment. Thyroid. 1997, 7:369-75. 10.1089\/thy.1997.7.369","journal-title":"Thyroid"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.78.1.8288723","article-title":"Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease","volume":"78","author":"Feldt-Rasmussen U","year":"1994","unstructured":"Feldt-Rasmussen U, Schleusener H, Carayon P. Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease. J Clin Endocrinol Metab. 1994, 78:98-102. 10.1210\/jcem.78.1.8288723","journal-title":"J Clin Endocrinol Metab"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1089\/105072502761016467","article-title":"Reduction of the risk of relapse after withdrawal of medical therapy for Graves' disease","volume":"12","author":"Orgiazzi J","year":"2002","unstructured":"Orgiazzi J, Madec AM. Reduction of the risk of relapse after withdrawal of medical therapy for Graves' disease. Thyroid. 2002, 12:849-53. 10.1089\/105072502761016467","journal-title":"Thyroid"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(77)92719-2","article-title":"Value of thyroid-stimulating-antibody determinations in predicting short-term thyrotoxic relapse in Graves' disease","volume":"1","author":"Davies TF","year":"1977","unstructured":"Davies TF, Yeo PP, Evered DC, Clark F, Smith BR, Hall R. Value of thyroid-stimulating-antibody determinations in predicting short-term thyrotoxic relapse in Graves' disease. Lancet. 1977, 1:1181-2. 10.1016\/s0140-6736(77)92719-2","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2009.06.033","article-title":"Clinical value of M22-based assays for TSH-receptor antibody (TRAb) in the follow-up of antithyroid drug treated Graves' disease: comparison with the second generation human TRAb assay","volume":"407","author":"Massart C","year":"2009","unstructured":"Massart C, Gibassier J, d'Herbomez M. Clinical value of M22-based assays for TSH-receptor antibody (TRAb) in the follow-up of antithyroid drug treated Graves' disease: comparison with the second generation human TRAb assay. Clin Chim Acta. 2009, 407:62-6. 10.1016\/j.cca.2009.06.033","journal-title":"Clin Chim Acta"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1992.2.155","article-title":"Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies","volume":"2","author":"McKenzie JM","year":"1992","unstructured":"McKenzie JM, Zakarija M. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid. 1992, 2:155-9. 10.1089\/thy.1992.2.155","journal-title":"Thyroid"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1999.9.727","article-title":"Fetal and neonatal hyperthyroidism","volume":"9","author":"Zimmerman D","year":"1999","unstructured":"Zimmerman D. Fetal and neonatal hyperthyroidism. Thyroid. 1999, 9:727-33. 10.1089\/thy.1999.9.727","journal-title":"Thyroid"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.13.1445","article-title":"Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy","volume":"158","author":"Fernandez-Soto L","year":"1998","unstructured":"Fernandez-Soto L, Gonzalez A, Escobar-Jimenez F, Vazquez R, Ocete E, Olea N, Salmeron J. Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy. Arch Intern Med. 1998, 158:1445-8. 10.1001\/archinte.158.13.1445","journal-title":"Arch Intern Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.k06-196","article-title":"TSH-receptor antibodies determined by the first, second and third generation assays and thyroid-stimulating antibody in pregnant patients with Graves' disease","volume":"54","author":"Kamijo K","year":"2007","unstructured":"Kamijo K. TSH-receptor antibodies determined by the first, second and third generation assays and thyroid-stimulating antibody in pregnant patients with Graves' disease. Endocr J. 2007, 54:619-24. 10.1507\/endocrj.k06-196","journal-title":"Endocr J"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-07-0450","article-title":"TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study","volume":"158","author":"Laurberg P","year":"2008","unstructured":"Laurberg P, Wallin G, Tallstedt L, Abraham-Nordling M, Lundell G, T\u00f8rring O. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. Eur J Endocrinol. 2008, 158:69-75. 10.1530\/EJE-07-0450","journal-title":"Eur J Endocrinol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-14-2-194","article-title":"Thyroid function and hyperfunction during gestation","volume":"14","author":"Burrow GN","year":"1993","unstructured":"Burrow GN. Thyroid function and hyperfunction during gestation. Endocr Rev. 1993, 14:194-202. 10.1210\/edrv-14-2-194","journal-title":"Endocr Rev"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/s0889-8529(05)70135-3","article-title":"Anti-TSH receptor antibodies in clinical practice","volume":"29","author":"Orgiazzi J","year":"2000","unstructured":"Orgiazzi J. Anti-TSH receptor antibodies in clinical practice. Endocrinol Metab Clin North Am. 2000, 29:339-55. 10.1016\/s0889-8529(05)70135-3","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1990.tb02472.x","article-title":"Anti TSH-receptor antibodies in pregnant patients with autoimmune thyroid disorder","volume":"97","author":"Clavel S","year":"1990","unstructured":"Clavel S, Madec AM, Bornet H, Deviller P, Stefanutti A, Orgiazzi J. Anti TSH-receptor antibodies in pregnant patients with autoimmune thyroid disorder. Br J Obstet Gynaecol. 1990, 97:1003-8. 10.1111\/j.1471-0528.1990.tb02472.x","journal-title":"Br J Obstet Gynaecol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-999676","article-title":"Universal predictive criteria for neonatal overt thyrotoxicosis requiring treatment","volume":"5","author":"Tamaki H","year":"1988","unstructured":"Tamaki H, Amino N, Aozasa M, et al.. Universal predictive criteria for neonatal overt thyrotoxicosis requiring treatment. Am J Perinatol. 1988, 5:152-8. 10.1055\/s-2007-999676","journal-title":"Am J Perinatol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2011.0087","article-title":"Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum","volume":"21","author":"Stagnaro-Green A","year":"2011","unstructured":"Stagnaro-Green A, Abalovich M, Alexander E, et al.. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011, 21:1081-125. 10.1089\/thy.2011.0087","journal-title":"Thyroid"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.8.7704","article-title":"Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy","volume":"86","author":"Kung AW","year":"2001","unstructured":"Kung AW, Lau KS, Kohn LD. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy. J Clin Endocrinol Metab. 2001, 86:3647-53. 10.1210\/jcem.86.8.7704","journal-title":"J Clin Endocrinol Metab"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030971","article-title":"No increase of blocking type anti-thyrotropin receptor antibodies during pregnancy in patients with Graves' disease","volume":"88","author":"Amino N","year":"2003","unstructured":"Amino N, Izumi Y, Hidaka Y, et al.. No increase of blocking type anti-thyrotropin receptor antibodies during pregnancy in patients with Graves' disease. J Clin Endocrinol Metab. 2003, 88:5871-4. 10.1210\/jc.2003-030971","journal-title":"J Clin Endocrinol Metab"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-999597","article-title":"Effective method for prediction of transient hypothyroidism in neonates born to mothers with chronic thyroiditis","volume":"6","author":"Tamaki H","year":"1989","unstructured":"Tamaki H, Amino N, Aozasa M, et al.. Effective method for prediction of transient hypothyroidism in neonates born to mothers with chronic thyroiditis. Am J Perinatol. 1989, 6:296-303. 10.1055\/s-2007-999597","journal-title":"Am J Perinatol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.81.3.8772590","article-title":"Incidence of transient congenital hypothyroidism due to maternal thyrotropin receptor-blocking antibodies in over one million babies","volume":"81","author":"Brown RS","year":"1996","unstructured":"Brown RS, Bellisario RL, Botero D, et al.. Incidence of transient congenital hypothyroidism due to maternal thyrotropin receptor-blocking antibodies in over one million babies. J Clin Endocrinol Metab. 1996, 81:1147-51. 10.1210\/jcem.81.3.8772590","journal-title":"J Clin Endocrinol Metab"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.03.030","article-title":"Clinical relevance of thyroid-stimulating immunoglobulins in Graves' ophthalmopathy","volume":"118","author":"Ponto KA","year":"2011","unstructured":"Ponto KA, Kanitz M, Olivo PD, Pitz S, Pfeiffer N, Kahaly GJ. Clinical relevance of thyroid-stimulating immunoglobulins in Graves' ophthalmopathy. Ophthalmology. 2011, 118:2279-85. 10.1016\/j.ophtha.2011.03.030","journal-title":"Ophthalmology"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199805213382114","article-title":"Therapy for hyperthyroidism and Graves' ophthalmopathy","volume":"338","author":"Gorman CA","year":"1998","unstructured":"Gorman CA, Offord KP. Therapy for hyperthyroidism and Graves' ophthalmopathy. N Engl J Med. 1998, 338:1546-7. 10.1056\/NEJM199805213382114","journal-title":"N Engl J Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1390584","article-title":"Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association","volume":"139","author":"Laurberg P","year":"1998","unstructured":"Laurberg P, Nygaard B, Glinoer D, Grussendorf M, Orgiazzi J. Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association. Eur J Endocrinol. 1998, 139:584-6. 10.1530\/eje.0.1390584","journal-title":"Eur J Endocrinol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/114736-utility-of-antibodies-in-the-diagnoses-of-thyroid-diseases-a-review-article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:12Z","timestamp":1707507672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/114736-utility-of-antibodies-in-the-diagnoses-of-thyroid-diseases-a-review-article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":44,"URL":"https:\/\/doi.org\/10.7759\/cureus.31233","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,8]]}}}